Breast cancer 21 gene test guides precise treatment

Share This Post

Breast cancer problem

Breast cancer is a common female malignant tumor that seriously threatens the physical and mental health of women, so it is also known as the “red killer”. Statistics show that breast cancer causes 458,000 deaths each year, and its incidence is increasing worldwide. In recent years, the incidence of breast cancer in India has risen rapidly, and there is a trend of youth. Breast cancer has become the most common cancer among Indian women. The number of new breast cancers and deaths in India each year account for 12.2% and 9.6% of the world’s total. 

Breast cancer treatment

Breast cancer is not terrible. Breast cancer treatment has achieved rapid progress. Breast cancer is one of the best treatments for breast cancer. According to statistics, the five-year survival rate for breast cancer in the United States is 89%, and the five-year survival rate for breast cancer patients in China is 73.1%. We can treat breast cancer as a chronic disease, not a terminal illness.

The treatment of breast cancer is mainly surgery + chemotherapy or radiotherapy. The conventional treatment is to remove the tumor lesion as much as possible. After the operation, radiotherapy and chemotherapy are used to kill the residual tumor cells and prevent tumor recurrence. However, scientific research shows that not all breast cancer patients need chemotherapy, and chemotherapy is not useful for some breast cancer patients. Unwanted chemotherapy also kills a large number of normal human cells, which is extremely harmful to women. Breast cancer gene tests invented by American scientists can help breast cancer patients avoid unnecessary chemotherapy. The occurrence, development, and metastasis of breast cancer are related to gene mutations. Breast cancer 21 gene testing can find these mutant genes, predict the probability of breast cancer patients’ recurrence, and help breast cancer patients choose or avoid chemotherapy. The whole-gene cancer test can screen targeted drugs to treat this mutation, to achieve the largest curative effect and the smallest toxic and side effects, and to achieve precise personalized treatment.

Genetic testing in breast cancer

Breast 21 oncogene testing can help doctors and patients decide on the best treatment options. Through the 21-gene test, observe the interaction between genes to determine the characteristics of the tumor, so as to predict the probability of breast cancer recurrence and the probability of possible benefit from chemotherapy. In other words, patients can know whether their breast cancer will recur through genetic testing, the probability of recurrence, determine whether breast cancer patients need postoperative chemotherapy, and how to avoid excessive chemotherapy. In order to determine more effective treatment options for breast cancer patients, to achieve sophisticated individualized treatment.

Breast cancer 21 gene test is beneficial for patients with early estrogen receptor positive (ER +), negative lymph node metastasis, and newly diagnosed breast cancer patients who will be treated with tamoxifen. It can predict the probability of breast cancer recurrence and the possibility of chemotherapy Benefit probability. After menopause, lymph node-positive and estrogen receptor-positive invasive breast cancer patients can also be genetically tested to determine whether the patient needs chemotherapy.

In recent years, through genetic testing to guide precise treatment, the 5-year survival rate and long-term survival rate of breast cancer patients have greatly improved. Breast cancer has become one of the solid tumors with the best curative effect.

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Risk of developing secondary tumors following CAR-T cell therapy is minimal - A Stanford Study
CAR T-Cell therapy

Risk of developing secondary tumors following CAR-T cell therapy is minimal – A Stanford Study

CAR-T cell therapy, a groundbreaking cancer treatment, carries a risk of developing secondary tumors. This occurs due to the therapy’s potential to cause genetic mutations or alter the immune system’s regulation. Secondary malignancies can arise from these changes, presenting a significant long-term risk for patients. Continuous monitoring and research are crucial to understanding and mitigating these risks, ensuring safer outcomes for those undergoing CAR-T cell therapy.

Seattle Children's Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients
CAR T-Cell therapy

Seattle Children’s Hospital to Start CAR T-Cell Clinical Trial for Pediatric Lupus Patients

Seattle Children’s Hospital is launching a groundbreaking CAR T-cell clinical trial for pediatric lupus patients. This innovative approach harnesses the body’s immune cells to target and eliminate lupus-affected cells, offering new hope for young patients with this autoimmune disorder. The trial represents a significant advancement in lupus treatment, aiming to improve outcomes and reduce long-term complications for children suffering from this challenging condition.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) Cancer treatment abroad?
2) CAR T-Cell therapy
3) Cancer vaccine
4) Online video consultation
5) Proton therapy